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Abstract
Background: Cytokine response plays a vital role in various human lipopolysaccharide (LPS) infectious and inflammatory
diseases. This study aimed to find genetic variants that might affect the levels of LPS-induced interleukin (IL)-6, IL-8, IL-10, IL-
1ra and tumor necrosis factor (TNF)-a cytokine production.
Methods: We performed an initial genome-wide association study using Affymetrix Human Mapping 500 K GeneChipH to
screen 130 healthy individuals of Danish descent. The levels of IL-6, IL-8, IL-10, IL-1ra and TNF-a in 24-hour LPS-stimulated
whole blood samples were compared within different genotypes. The 152 most significant SNPs were replicated using
Illumina Golden GateH GeneChip in an independent cohort of 186 Danish individuals. Next, 9 of the most statistical
significant SNPs were replicated using PCR-based genotyping in an independent cohort of 400 Danish individuals. All results
were analyzed in a combined study among the 716 Danish individuals.
Results: Only one marker of the 500 K Gene Chip in the discovery study showed a significant association with LPS-induced
IL-1ra cytokine levels after Bonferroni correction (P,1027). However, this SNP was not associated with the IL-1ra cytokine
levels in the replication dataset. No SNPs reached genome-wide significance for the five cytokine levels in the combined
analysis of all three stages.
Conclusions: The associations between the genetic variants and the LPS-induced IL-6, IL-8, IL-10, IL-1ra and TNF-a cytokine
levels were not significant in the meta-analysis. This present study does not support a strong genetic effect of LPS-
stimulated cytokine production; however, the potential for type II errors should be considered.
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Introduction
Lipopolysaccharide (LPS) is an amphiphilic molecule present at
high concentrations on the outer membrane of Gram-negative
bacteria. LPS is of crucial importance, as it protects cell
membranes from chemical attack and helps stabilizing the overall
membrane structure of the Gram-negative bacteria [1]. In
mammals, LPS is an endotoxin which stimulates and induces a
response from the mammalian innate immune system. The
mechanism by which LPS is brought to the surface of responsive
immune cells and initiates inflammatory responses begins with
binding to lipid binding proteins (LBP) in human serum. After
binding to LBP, LPS will be transferred to CD14 which is
expressed as a membrane-bound glycoprotein on the cell surface
of monocytes, macrophages and neutrophiles. The binding of LPS
to CD14 leads to the recruitment of the toll-like receptor 4 (TLR4)
molecule which is able to mediate signals which activate a broad
range of genes, including those for IL-1ra (anti-inflammatory), IL-
6 (pro-inflammatory), IL-8 (pro-inflammatory) and IL-10 (pre-
dominantly anti-inflammatory) and TNF-a (pro-inflammatory); all
are important mediators in the regulation of the immune response
and inflammatory process [2].
Association studies between IL-1ra, IL-6, IL-8, IL-10 and TNF-
a levels and polymorphisms in the genes encoding these cytokines
have been reported with inconsistent results [3]. However, it has
been suggested that the production and levels of cytokines may be
influenced by genes outside their primary coding loci [4] for
example by regulatory single-nucleotide polymorphisms (rSNP)
[5]. A few genome-wide association studies (GWAS) considering
association of heritable components in the variation of cytokine
production have been reported [3,4,5]. We conducted a GWAS of
the following five cytokines; IL-1ra, IL-6, IL-8, IL-10 and TNF-a,
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in population-based LPS-stimulated blood samples of healthy
Danish individuals.
Materials and Methods
Samples and Study Design
The study design is summarized in figure 1.
Individuals included in this study were healthy Danish blood
donors (382 women and 334 men) from Copenhagen University
Hospital, Rigshospitalet, Denmark. Blood samples were obtained
by using the remaining blood from the side portion collected at
blood donation. Data collected from each participant included sex
and a blood sample. The study was approved by the Central
Medical Scientific Ethics Committee of Denmark (KF 01–024/01
and KF 11303898). Oral and written informed consent was
obtained from the first included participants (n=130, discovery
phase). The remaining samples included in the study (replication
phase 1 and 2) were all spare blood handled anonymously and
could thus be used without collection of informed consent form
according to Danish regulations (act no 593 of 14 June 2011).
LPS-stimulation and Cytokine Assessment
All blood samples were diluted 1:4 with RPMI, and then 2 ml of
each sample was stimulated with 20 ml of LPS (100 mg/ml)
(Sigma-Aldrich, Copenhagen, Denmark). Afterwards, the samples
were incubated at 37uC with 5% CO2 for 24 hours, followed by
centrifugation at 2500 crp for 10 min. The supernatants were
harvested by gently pipetting and subsequently frozen and stored
at -80uC.Concentrations of the cytokines IL-1ra, IL-6, IL-8, IL-10
and TNF-a were quantified by a Luminex 100 platform (Luminex
Corporation, Austin, TX) using R&D Human FluorokineH MAP
assays (R&D SystemsH, Cary, NC). Analyses were performed
according to the manufacturer’s suggested protocol.
Genotyping
We performed a genome-wide association study in 130 Danish
individuals using the Affymetrix Human Mapping 500 K
GeneChipH to search for genetic variants that influence LPS-
stimulated cytokine production (discovery stage). Next, 152
candidate SNPs from the 500 k GeneChip analysis were
investigated further in 186 Danish individuals using the Illumina
Golden GateH GeneChip (first replication stage). Results from the
first two stages were analyzed in a combined study, from which 9
identified SNPs with top-ranked P-values were investigated in 400
Danish individuals (second replication stage) using the Kbios-
ciences PCR genotyping system (KASPar) as an in-house service at
KBiosciences. Finally, we analyzed the same data for all three
stages in a meta-analysis to identify associations between gene
variants and IL-6, IL-8, IL-10, IL-1ra and TNF-a cytokine
response related to LPS stimulation. As the genotype and
phenotype data for the current study will not be publicly available,
we kindly request readers to contact corresponding author for any
further information on the dataset.
Quality Control and SNPs Chosen for Replication
Inbreeding coefficients were estimated on the X chromosome in
order to determine gender. All individuals inferred gender
matched the reported gender. The inbreeding coefficients were
also estimated based on the autosome using a method of moment
estimator. Extreme values of this coefficient are either a sign of
inbreeding or genotype errors. All individuals had an inbreeding
coefficient close to 0 (-0.06 to 0.06). Signs of batch effects or
population structure were evaluated using both multi dimensional
scaling based on the identical state matrix which showed no signs
of clustering. Pairwise relatedness was estimated between all
subjects and close relationships (1 cousins or closer) were removed
from the analysis. Genotyping errors were determined using 6
duplicated samples which showed a discordance rate of 0.3% using
the BRLMM (Bayesian Robust Linear Model with Mahalanobis
Distance Classifier) call confidence score above 0.5. In the
discovery stage only SNPs with a P-value equal to or less than
0.0001 to the LPS trait were selected for further analysis. Then
SNPs with a minor allele frequency (MAF) of less than 0.05 and
SNPs where Hardy-Weinberg equilibrium were rejected with a P-
value less than 0.001 were removed. Afterwards, the SNPs from
the discovery stage were trimmed so that no pair of SNPs (using
10 SNP window) were in high linkage disequilibrium (R2.0.8)
where the less associated SNPs were removed.
Study Design and Statistical Analysis
Cytokine levels were evaluated between men and women by
analysis of covariance (ANCOVA).
Normality of the IL-6, IL-8, IL-10, IL-1ra and TNF-a
quantitative phenotypes were assessed using descriptive statistics
and distribution plots (histograms and q-q plots). None of the
cytokines were normally distributed; therefore, values were natural
log-transformed prior to genome-wide analysis. The analysis was
done in PLINK statistical software by using linear regression
models under an additive genetic model with adjustment for sex.
The 152 top-scoring SNPs from the initial discovery cohort were
genotyped further in 186 healthy individuals (replication stage 1)
followed by a combined analysis. Then, 9 of the 152 SNPs which
reached the most significant values in a combined analysis of
discovery phase and replication stage 1 were genotyped in 400
individuals (replication stage 2). Afterwards, results from SNPs
typed in all of the three stages were combined in a meta-analysis,
from which estimated heterogeneity variance and forest plots from
each stage and the combined analysis were generated. In order to
compensate for the number of tests performed, the obtained P-
values needed to pass the Bonferroni adjustment and permutation
testing. Bonferroni adjustment was simply done by dividing 0.05
by 5?105 tests giving a P-value of 161027. Adjustment for multiple
testing was also performed using a permutation procedure. This
was done by permuting the trait labels randomly between samples.
The highest test statistic across the whole genome was saved in
each iteration in order to obtain an empirical null distribution that
corrects for the multiple testing. Power calculation was performed
using Bioconductor’s GeneticsDesign showing that minor allele
frequencies of 50%, 20% and 10% have 80% power to detect a
difference between groups of 0.456 SD, 0.876 SD and 0.996
SD respectively.
Figure 1. Study design illustrating the genome-wide associa-
tion (GWA) study approach.
doi:10.1371/journal.pone.0066262.g001
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Results
Cytokine levels of all the study subjects after 24 hour of LPS
stimulation are presented in table 1. There were no differences in
IL-6, IL-8, IL-10 and TNF-a cytokine levels between men and
women; however, women had significantly higher IL-1ra levels
than men (P=0.002), therefore sex is included in the general linear
model.
GWA Analysis (Discovery Stage)
Figure 2 shows Manhattan plots of the P-values of the
Affymetrix Human Mapping 500 K GeneChip in the discovery
phase; results are presented for the sex-combined (n=130)
analysis. One of these SNPs (rs12512853, P=1.361028) on
chromosome 4 was associated with the produced IL-1ra levels with
a genome-wide significant P-value (P,161027) after adjustment
for sex. This significance is maintained through a Bonferroni
correction, figure 2 (IL-1ra). No SNP reached genome-wide
significance for the other four cytokine production levels. Yet,
significance was not evident after the rs12512853 IL-1ra SNP was
corrected for multiple testing using the permutation procedure
(P=1.661026). We selected the top 152 most associated LPS-
stimulated SNPs for further analysis and confirmation in a new
sample, replication stage 1 (n = 186). The top 152 most associated
LPS-stimulated SNPs selected for the first replication stage are
presented in Table S1.
Table 1. The untransformed cytokine levels (pg/ml) measured in supernatants after 24 hours LPS-stimulation from the healthy
individuals included in this genome-wide association study.
Cytokine Mean (pg/ml) ± SD P-value
Overall (n=716) Men (n=334) Women (n=382)
IL-1ra 35870611472 34422611149 37135611616 0.002
IL-6 1639865778 1669765709 1613865833 0.20
IL-8 1138266255 1176165904 1105266537 0.13
IL-10 3746302 3676249 3826343 0.51
TNF-a 302161742 314161663 291661804 0.08
P-values show significance of mean concentration difference between men and women by two-sample T-test of means.
doi:10.1371/journal.pone.0066262.t001
Figure 2. Manhattan plots showing P-values of association of each of the SNPs in the analysis with LPS stimulated plasma cytokine
levels. SNPs are plotted on the X-axis to their position on each chromosome against cytokine levels on the Y-axis (shown as –log10 P-value).
doi:10.1371/journal.pone.0066262.g002
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Replication Analysis and Combined Analysis (Replication
Stage 1 and 2)
None of the 152 best associated SNPs from the discovery stage
were statistically significant after adjustment for multiple testing in
replication stage 1. We chose the top 9 SNPs from the first
replication stage to be further analyzed in a second replication
stage. Association analysis of the 9 most interesting SNPs, solely
based on the P-values, was done for the three individual stages and
Figure 3. Forest plots of meta-analysis of each selected SNP on the cytokine production. The x-axis represents the estimated effect sizes
in mean differences. The horizontal lines show the stage-specific estimated effect sizes and the corresponding 95% confidence intervals of the natural
logarithmic mean differences. The solid vertical line at 0 means no difference in effect size.
doi:10.1371/journal.pone.0066262.g003
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for the combined stages; the results are shown in table 2 and
figure 3. The forest plots in figure 3 allow a visual assessment of the
amount of variation between the results of the different stages,
which shows that results in the current study are heterogeneous.
The results from the meta-analysis show that after being corrected
for multiple testing none of the SNPs associated with cytokine
levels after 24 hour of LPS treatment.
The results from the discovery stage could not be replicated in
any of the further analysis done in the replication stages and meta-
analysis. No association between genetic variants and LPS-
stimulated IL-6, IL-8, IL-10 and TNF-a cytokine levels was seen
in healthy Danish blood donors.
Discussion
In general, when performing GWAS with quantitative mea-
surements, the potential for type I errors can be high. However,
Bonferroni is a very conservative correction and the association of
a given genetic variant on cytokine level might be too small to
reach genome wide significance when comparing 500,000 tests. As
for any empirical research, the statistical power for GWAS is of
critical importance. As an example, we had 80% power to detect
an effect size of 0.876SD between groups with a minor allele
frequency of 20%. According to our sample size, minor or modest
effects of genetic variants on the produced cytokine levels might be
missed in the current study.In the discovery stage we found
significant SNPs of whom one SNP also passed the Bonferroni
correction. This SNP did not reach significant level after
permutation-based correction for multiple testing; this might be
because the phenotype is not completely normally distributed and
the statistics might be inflated giving artificially low P-values. This
distorts the type I error for the asymptotic test and makes the
permutation procedure less powerful. However, none of these
SNPs could be replicated in the further stages. From the meta-
analysis illustrated in the forest plot we see some wide confidence
intervals for all of the studies. This indicates that we have a low
power in the three stages. As the mean values are logarithmic,
some differences in effect sizes can be missed. An effect difference
of 0.2 on the x-axis on the forest plot (figure 3) is actually a 1.2 fold
difference (e0.2 = 1.2) in mean cytokine level. Therefore some of
the SNPs which show the same direction of effect on mean values,
even though not significant, is relevant to be further investigated in
a new set-up.
Among healthy individuals the cytokine production is known to
be influenced by factors such as age, BMI, and ethnicity. Our
study population only included Caucasian individuals; however,
we did not obtain information about their parental and
grandparental ancestry. Furthermore, we did not adjust for age
in the analysis. These factors might have an impact on the results
obtained.
However, the mentioned factors are just speculative in this
current study and should be further investigated in determining
the possible effect on the cytokine production.
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Table S1 Top 152 SNPs showing the highest evidence of
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Table 2. Top 9 SNPs showing the highest evidence of association with IL-6, IL-8, IL-10, IL-1ra and TNF-a LPS stimulated plasma
levels among healthy individuals with the most associated P-values ,561025 in the discovery stage or P-values ,0.05 in the first
replication stage (n= 716).
Cytokine SNP Chr Position
P-value
discovery
P-value
replication 1
P-value
replication 2
P-value
combined Het
IL-10 rs1477748 12 75738812 2.1?1025 0.18 0.97 0.0037 0.012
TNF-a rs2460620 15 44085750 1.3?1026 0.19 0.59 0.0011 0.0034
IL-6 rs3770775 2 37033711 3.7?1026 0.37 0.3 0.0017 0.0037
IL-1ra rs3770775 2 37033711 1.6?1026 0.025 0.59 3.5?1024 0.0019
IL-1ra rs6672862 1 236850434 1.2?1025 0.1 0.78 0.0043 0.0033
IL-6 rs11090463 22 25707569 1.8?1025 0.78 0.44 0.0078 0.0045
IL-10 rs11090463 22 25707569 5.3?1025 0.014 1.0 5.1?1024 0.0071
TNF-a rs11807669 1 94842702 1.4?1024 0.056 0.33 2.3?1024 0.11
TNF-a rs12750215 1 87927757 1.1?1024 0.11 0.71 0.22 5?1024
IL-6 rs17080889 13 19837136 3.7?1025 0.37 0.31 0.0026 0.024
IL-6 rs17170416 7 33781320 2.7?1024 0.7 0.96 0.011 0.03
Chromosomal positions are from NCBI build 36 (hg 18).
doi:10.1371/journal.pone.0066262.t002
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